"Litigating Biotech Patent Cases" at the conference "Dealing in Life and Drugs: Contemporary Issues in the Business of Biotechnology," sponsored by the TECHLAW Group
This event has already occurred.
Related Insights
Amgen Files Three New Prolia® / Xgeva® BPCIA Litigations Against Hikma, Shanghai Henlius Biotech, and Biocon’s Proposed Biosimilars